Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral Palsy
1 other identifier
observational
300
1 country
4
Brief Summary
The investigators hope to use MRI biomarkers to identify and characterize sensorimotor network disruption patterns associated with chronic pain and sensory deficits in CP. Investigators will use existing information in the medical record as well as subjective reports from interview, physical exam data, and anatomical and functional MRI data to non-invasively identify brain injury correlates of pain and sensory deficits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2018
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 4, 2018
CompletedFirst Submitted
Initial submission to the registry
December 14, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2026
CompletedMay 2, 2025
May 1, 2025
7.3 years
December 14, 2021
May 1, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Regional brain/spine volumes
Regional volumes will be measured using MR processing software
<3 months
Diffusion scalars
Diffusion scalars for tracts of interest including the posterior thalamic radiations as well as somatosensory association fibers and the spinothalamic tract
<3 months
Study Arms (4)
Participants with CP (survey-only)
Subjects in this group are age 8 and older with a diagnosis of cerebral palsy. Participants are either able to affirmatively consent or assent with LAR consent. This sample will have a CFCS score ranging between 1 and 3 and should be able to unambiguously respond to a 65 item multiple choice survey.
Neurotypical participants (survey-only)
Subjects in this group are age 8 and older with no clinically significant neurologic or developmental diagnosis. Participants are either able to affirmatively consent or assent with LAR consent.
Participants with CP (Survey + MRI)
Subjects are 8 years or older with a diagnosis of cerebral palsy and clinical imaging demonstrating isolated periventricular white matter injury. Clinical assessment states that neurologic symptoms are attributed to this isolated injury. Subjects in this group must be able to lie still in a scanner for 1.5 hours in at most 2 sessions and be able to have an MRI. Participants must be able to affirmatively consent or assent with LAR consent.
Neurotypical participants (Survey + MRI)
Subjects in this group are age 8 and older with no clinically significant neurologic or developmental diagnosis. Participants are able to affirmatively consent and are able to have an MRI. Subjects also should be able to lie still in a scanner for 1.5 hours.
Interventions
Research unsedated MRI scans (outside of usual care) will be performed using a 3T Philips scanner at the F.M. Kirby Research Center. An MRI scanning protocol will be at the F.M. Kirby Research Center; the protocol will not last more than 1.5 hours. Acquisitions will include a triplanar survey, functional and anatomical multi-slice imaging of the brain as well as MRI of selected spinal levels. Protocols will be used that do not involve use of contrast agents and limit power/tissue absorption as well as otherwise remain within FDA and Kirby Center safety regulations. When possible, MRI will be performed within 3 months of initial survey/interview administration. If MRI is scheduled \>3 months after initial survey/interview administration, a brief survey will be re-administered to screen for changes in pain/clinical status.
Eligibility Criteria
Children and adults with cerebral palsy and typically-developing adults and children
You may qualify if:
- Individual 8+ years of age
- Diagnosis of cerebral palsy
You may not qualify if:
- None
- Neurotypical participants: (Survey-only):
- Individual 8+ years of age
- Adult subject able to indicate understanding and affirmative consent OR Adult/child subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
- Clinically-significant neurologic or developmental diagnosis
- Participants with CP (Survey and MRI):
- Individual 8+ years of age
- Adult subject able to indicate understanding and affirmative consent OR Adult subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
- Diagnosis of cerebral palsy
- Clinical imaging demonstrating isolated periventricular white matter injury
- Clinical judgment that all neurologic symptoms are attributable to non-progressive periventricular white matter injury
- Able to lie still in scanner for 1.5 hours in at most 2 sessions and be able to have MRI
- None
- Neurotypical participants (Survey and MRI):
- Individual 8+ years of age
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.lead
- Johns Hopkins Universitycollaborator
- Mount Washington Pediatric Hospitalcollaborator
- Neurosurgery Pain Research Institutecollaborator
- Cerebral Palsy Alliancecollaborator
Study Sites (4)
F.M. Kirby Center
Baltimore, Maryland, 21205, United States
Mt. Washington Pediatric Hospital
Baltimore, Maryland, 21209, United States
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Kennedy Krieger Institute
Baltimore, Maryland, 21287, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Chin, MD
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2021
First Posted
January 20, 2022
Study Start
December 4, 2018
Primary Completion
April 7, 2026
Study Completion
April 7, 2026
Last Updated
May 2, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share